Nephros, Inc. (NEPH) compared with its closest peers (STSS, CVRX, DRIO, SRTS, MDAI): P/E 37.6 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Sharps Technology, Inc. (STSS) | $77.87M | -0.0 |
| CVRx, Inc. (CVRX) | $75.53M | -3.5 |
| DarioHealth Corp. (DRIO) | $73.40M | 0.6 |
| Sensus Healthcare, Inc. (SRTS) | $53.17M | -8.4 |
| Spectral AI, Inc. (MDAI) | $50.53M | -4.9 |
| Xtant Medical Holdings, Inc. (XTNT) | $46.75M | 26.0 |
| PAVmed Inc. (PAVM) | $42.42M | -0.0 |
| SANUWAVE Health, Inc. (SNWV) | $42.05M | 2.6 |
| Accuray Incorporated (ARAY) | $34.50M | — |
| Plus Therapeutics, Inc. (PSTV) | $29.37M | -1.8 |
| Stock P/E | 37.6 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 74.1% |
| vs Industry | 14.4% |
NEPH overview · NEPH earnings · NEPH financials · NEPH KPIs · NEPH investor relations · NEPH ownership · NEPH filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.